Doxorubicin: The dogma and the bone

Bibliographic Details
Published in:	Asian Journal of Pharmaceutical Sciences
Main Authors:	Jia Y. Wong, Pornsak Sriamornsak, Crispin R. Dass
Format:	Article
Language:	English
Published:	Elsevier 2016-02-01
Subjects:	Doxorubicin Cancer Tumour Apoptosis Cardiotoxicity
Online Access:	http://www.sciencedirect.com/science/article/pii/S1818087615001166

Similar Items

Anti-apoptotic effects of minocycline on doxorubicin-induced cardiotoxicity in male Wistar rats
by: Hossein Piri, et al.
Published: (2023-12-01)

Characterization and in vitro release studies of oral microbeads containing thiolated pectin–doxorubicin conjugates for colorectal cancer treatment
by: Kamonrak Cheewatanakornkool, et al.
Published: (2017-11-01)

PEG-conjugated bovine haemoglobin enhances efficiency of chemotherapeutic agent doxorubicin with alleviating DOX-induced splenocardiac toxicity in the breast cancer
by: Bingting Li, et al.
Published: (2023-12-01)

Lipid Emulsion Inhibits the Late Apoptosis/Cardiotoxicity Induced by Doxorubicin in Rat Cardiomyoblasts
by: Raghavendra Baregundi Subbarao, et al.
Published: (2018-09-01)

Investigate if Metoprolol and Troxerutin Could Prevent Cardiotoxicity Mitigated by Doxorubicin
by: Fouad Zeidan Hamzah, et al.
Published: (2025-07-01)

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
by: Himani Kumari, et al.
Published: (2020-05-01)

PPARα Ameliorates Doxorubicin-Induced Cardiotoxicity by Reducing Mitochondria-Dependent Apoptosis via Regulating MEOX1
by: Wei Wang, et al.
Published: (2020-10-01)

Rutaecarpine Inhibits Doxorubicin-Induced Oxidative Stress and Apoptosis by Activating AKT Signaling Pathway
by: Zi-Qi Liao, et al.
Published: (2022-01-01)

Apigenin-coated gold nanoparticles as a cardioprotective strategy against doxorubicin-induced cardiotoxicity in male rats via reducing apoptosis
by: Zeynab Sharifiaghdam, et al.
Published: (2023-03-01)

The function of PCSK9 in doxorubicin-induced cardiotoxicity and its underlying mechanism
by: Shuai Shi, et al.
Published: (2025-07-01)

Lipidomics application to explain acute cardiotoxicity induced by doxorubicin
by: Lubna Zuhair Abdul Karim, et al.
Published: (2019-12-01)

Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity
by: Sebahat Ulusan, et al.
Published: (2023-05-01)

Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01)

Danhong injection attenuates doxorubicin-induced cardiotoxicity in rats via suppression of apoptosis: network pharmacology analysis and experimental validation
by: Xiaojiao Yi, et al.
Published: (2022-08-01)

Hyperoside alleviates doxorubicin-induced myocardial cells apoptosis by inhibiting the apoptosis signal-regulating kinase 1/p38 pathway
by: Lingxia Chen, et al.
Published: (2023-05-01)

Columbianadin attenuates doxorubicin-induced cardiac injury, oxidative stress, and apoptosis via Sirt1/FOXO1 signaling pathway
by: Bo Peng, et al.
Published: (2023-06-01)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
by: Manrose Singh, et al.
Published: (2022-01-01)

Cardioprotective effects of deferoxamine in acute and subacute cardiotoxicities of doxorubicin: a randomized clinical trial
by: Kosar Rahimi, et al.
Published: (2023-03-01)

Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer
by: Atefeh Ghahremanloo, et al.
Published: (2025-03-01)

CYP2J2-derived epoxyeicosatrienoic acids protect against doxorubicin-induced cardiotoxicity by reducing oxidative stress and apoptosis via activation of the AMPK pathway
by: Chuanmeng Zhu, et al.
Published: (2024-01-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

Cryptotanshinone Ameliorates Doxorubicin-Induced Cardiotoxicity by Targeting Akt-GSK-3β-mPTP Pathway In Vitro
by: Xiaoping Wang, et al.
Published: (2021-03-01)

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Irwin K. Cheah, et al.
Published: (2023-01-01)

Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
by: Maria Isabel Camara Planek, et al.
Published: (2020-07-01)

Antianemia Drug Roxadustat (FG-4592) Protects Against Doxorubicin-Induced Cardiotoxicity by Targeting Antiapoptotic and Antioxidative Pathways
by: Guangfeng Long, et al.
Published: (2020-08-01)

Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2
by: Jie Wang(a), et al.
Published: (2022-06-01)

Cardiotoxicity of doxorubicin – causes, prevention, prospects
by: Paweł Wesołowski, et al.
Published: (2022-11-01)

Cardiotoxicity of doxorubicin: Causes, diagnosis, consequences and possibilities of prevention
by: Radić Jelena P., et al.
Published: (2022-01-01)

The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review
by: Rony Abdi Syahputra, et al.
Published: (2022-02-01)

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer
by: Cochera F, et al.
Published: (2018-07-01)

Evaluation of Doxorubicin Cardiomyopathy by Signal Averaged Electrocardiography
by: HAKAN SAKALLI, et al.
Published: (2013-04-01)

Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better?
by: Hadeel Halalsheh, et al.
Published: (2023-07-01)

Efficacy and cardiovascular safety of liposomal doxorubicin: a systematic review and meta-analysis of randomized trials
by: Germano Dallegrave Cavalli, et al.
Published: (2025-10-01)

Juvenile exposure to doxorubicin alters the cardiovascular response to adult-onset psychosocial stress in mice
by: Marianne K. O. Grant, et al.
Published: (2022-01-01)

Potential role of endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity-an update
by: Mingli Sun, et al.
Published: (2024-08-01)

Cardioprotective effects of Rhododendron arboreum leaf extract against Doxorubicin-induced cardiotoxicity in Wistar rats by modulating electrocardiographic and cardiac biomarkers
by: Adersikha Pradhan, et al.
Published: (2023-11-01)

Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group
by: Lisa M. Kopp, et al.
Published: (2019-10-01)

Cardioprotective potential of protocatechuic acid against doxorubicin-induced cardiotoxicity in rats
by: Leila Safaeian, et al.
Published: (2025-01-01)

CREG1 attenuates doxorubicin-induced cardiotoxicity by inhibiting the ferroptosis of cardiomyocytes
by: Dan Liu, et al.
Published: (2024-09-01)

EPAC1 inhibition protects the heart from doxorubicin-induced toxicity
by: Marianne Mazevet, et al.
Published: (2023-08-01)